Janus kinase/signal transducer and activator of transcription pathways in spondyloarthritis

Smriti K. Raychaudhuri, Siba P Raychaudhuri

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Cytokines are major drivers of autoimmunity, and biologic agents targeting cytokines have revolutionized the treatment of immune-mediated diseases. Janus kinase/signal transducer and activator of transcription (JAK-STAT) pathway represents a group of several intracellular molecules with a key role in signal pathways activated by growth factors and cytokines. These kinase proteins are associated with the signaling process of multiple key cytokines, which regulates various T-cell subpopulations and their effector cytokines. Development of novel drugs to inhibit this kinase cascade is an emerging field in clinical immunology. Thus, it is essential to have insights about the regulatory role of the JAK-STAT cytokine signaling in relation to autoimmune diseases and its applications in spondyloarthritis. RECENT FINDINGS: JAK-STAT kinase signaling proteins have been extensively studied in rheumatoid arthritis. Initial observations suggest that JAK-STAT kinase signaling cascade regulates activation and proliferation of the IL17 effector memory T cells and thus has a potential role in the pathogenesis of psoriasis, psoriatic arthritis and ankylosing spondylitis. SUMMARY: Here, we provide an overview of the clinical rheumatologists about the significance of JAK-STAT signaling system in rheumatic diseases and introduce the potential application of JAK and STAT inhibitors in spondyloarthritis.

Original languageEnglish (US)
JournalCurrent Opinion in Rheumatology
DOIs
StateAccepted/In press - Apr 7 2017

Fingerprint

Janus Kinases
Transducers
Cytokines
Protein Kinases
Phosphotransferases
T-Lymphocytes
Psoriatic Arthritis
Ankylosing Spondylitis
Immune System Diseases
Biological Factors
Allergy and Immunology
Rheumatic Diseases
Autoimmunity
Psoriasis
Autoimmune Diseases
Signal Transduction
Rheumatoid Arthritis
Intercellular Signaling Peptides and Proteins
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Rheumatology

Cite this

Janus kinase/signal transducer and activator of transcription pathways in spondyloarthritis. / Raychaudhuri, Smriti K.; Raychaudhuri, Siba P.

In: Current Opinion in Rheumatology, 07.04.2017.

Research output: Contribution to journalArticle

@article{9e392230c3814e5eaf6177fce834e1e4,
title = "Janus kinase/signal transducer and activator of transcription pathways in spondyloarthritis",
abstract = "PURPOSE OF REVIEW: Cytokines are major drivers of autoimmunity, and biologic agents targeting cytokines have revolutionized the treatment of immune-mediated diseases. Janus kinase/signal transducer and activator of transcription (JAK-STAT) pathway represents a group of several intracellular molecules with a key role in signal pathways activated by growth factors and cytokines. These kinase proteins are associated with the signaling process of multiple key cytokines, which regulates various T-cell subpopulations and their effector cytokines. Development of novel drugs to inhibit this kinase cascade is an emerging field in clinical immunology. Thus, it is essential to have insights about the regulatory role of the JAK-STAT cytokine signaling in relation to autoimmune diseases and its applications in spondyloarthritis. RECENT FINDINGS: JAK-STAT kinase signaling proteins have been extensively studied in rheumatoid arthritis. Initial observations suggest that JAK-STAT kinase signaling cascade regulates activation and proliferation of the IL17 effector memory T cells and thus has a potential role in the pathogenesis of psoriasis, psoriatic arthritis and ankylosing spondylitis. SUMMARY: Here, we provide an overview of the clinical rheumatologists about the significance of JAK-STAT signaling system in rheumatic diseases and introduce the potential application of JAK and STAT inhibitors in spondyloarthritis.",
author = "Raychaudhuri, {Smriti K.} and Raychaudhuri, {Siba P}",
year = "2017",
month = "4",
day = "7",
doi = "10.1097/BOR.0000000000000399",
language = "English (US)",
journal = "Current Opinion in Rheumatology",
issn = "1040-8711",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Janus kinase/signal transducer and activator of transcription pathways in spondyloarthritis

AU - Raychaudhuri, Smriti K.

AU - Raychaudhuri, Siba P

PY - 2017/4/7

Y1 - 2017/4/7

N2 - PURPOSE OF REVIEW: Cytokines are major drivers of autoimmunity, and biologic agents targeting cytokines have revolutionized the treatment of immune-mediated diseases. Janus kinase/signal transducer and activator of transcription (JAK-STAT) pathway represents a group of several intracellular molecules with a key role in signal pathways activated by growth factors and cytokines. These kinase proteins are associated with the signaling process of multiple key cytokines, which regulates various T-cell subpopulations and their effector cytokines. Development of novel drugs to inhibit this kinase cascade is an emerging field in clinical immunology. Thus, it is essential to have insights about the regulatory role of the JAK-STAT cytokine signaling in relation to autoimmune diseases and its applications in spondyloarthritis. RECENT FINDINGS: JAK-STAT kinase signaling proteins have been extensively studied in rheumatoid arthritis. Initial observations suggest that JAK-STAT kinase signaling cascade regulates activation and proliferation of the IL17 effector memory T cells and thus has a potential role in the pathogenesis of psoriasis, psoriatic arthritis and ankylosing spondylitis. SUMMARY: Here, we provide an overview of the clinical rheumatologists about the significance of JAK-STAT signaling system in rheumatic diseases and introduce the potential application of JAK and STAT inhibitors in spondyloarthritis.

AB - PURPOSE OF REVIEW: Cytokines are major drivers of autoimmunity, and biologic agents targeting cytokines have revolutionized the treatment of immune-mediated diseases. Janus kinase/signal transducer and activator of transcription (JAK-STAT) pathway represents a group of several intracellular molecules with a key role in signal pathways activated by growth factors and cytokines. These kinase proteins are associated with the signaling process of multiple key cytokines, which regulates various T-cell subpopulations and their effector cytokines. Development of novel drugs to inhibit this kinase cascade is an emerging field in clinical immunology. Thus, it is essential to have insights about the regulatory role of the JAK-STAT cytokine signaling in relation to autoimmune diseases and its applications in spondyloarthritis. RECENT FINDINGS: JAK-STAT kinase signaling proteins have been extensively studied in rheumatoid arthritis. Initial observations suggest that JAK-STAT kinase signaling cascade regulates activation and proliferation of the IL17 effector memory T cells and thus has a potential role in the pathogenesis of psoriasis, psoriatic arthritis and ankylosing spondylitis. SUMMARY: Here, we provide an overview of the clinical rheumatologists about the significance of JAK-STAT signaling system in rheumatic diseases and introduce the potential application of JAK and STAT inhibitors in spondyloarthritis.

UR - http://www.scopus.com/inward/record.url?scp=85017262430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017262430&partnerID=8YFLogxK

U2 - 10.1097/BOR.0000000000000399

DO - 10.1097/BOR.0000000000000399

M3 - Article

JO - Current Opinion in Rheumatology

JF - Current Opinion in Rheumatology

SN - 1040-8711

ER -